Navigation Links
EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference
Date:12/5/2007

TARRYTOWN, N.Y., Dec. 5 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Jack Talley, President and CEO, will present a company overview at the New York Society of Security Analysts ("NYSSA") 11th Annual Biotech & Specialty Pharma Conference on December 12, 2007 at 4:05 p.m. Eastern Time. The conference will be held at the NYSSA's headquarters at 1177 Avenue of the Americas in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The presentation will be available live via webcast on December 12, 2007. The webcast can be accessed by visiting http://www.epicept.com. A replay of the presentation will be available for 90 days following the event.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's broad portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound is approaching a decision in Europe. In addition, EpiCept's ASAP technology, a proprietary live cell high- throughput caspase-3 screening technology, can efficiently identify new cancer drug candidates and molecular targets that selectively induce apoptosis in cancer cells. Two oncology drug candidates currently in clinical development that were discovered using this technology have also been shown to act as vascular disruption agents in a variety of solid tumors.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. EpiCept Corporation to Present at the 2007 BIO InvestorForum
2. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
3. EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
5. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
6. EpiCept Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
7. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
8. EpiCept Announces Presentation of New Ceplene(TM) Data at the 49th Annual Meeting of the American Society of Hematology
9. EpiCept Corporation Announces Pricing of Public Offering
10. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... As the age of marriage and ... as a way to ensure future family building options ... advancing reproductive age. Vitrification technology, a fast freeze method ... technology that allows a woman to have multiple eggs ... which are then stored for future use. When circumstances ...
(Date:7/24/2014)... scientists at Carnegie Mellon University, working with high-throughput ... Berkeley National Laboratory, have devised a computational method ... normal breast cells turn malignant and as they ... for analyzing how genes interact with each other ... published today by the online journal PLOS ...
(Date:7/24/2014)... 2014 In a recent report by CBS ... put an end to criminal penalties associated with possession of ... for marijuana reform in Washington DC, giving it one of ... replaces criminal penalties for possession of one ounce of marijuana ... possession of more than an ounce of marijuana remain criminal ...
(Date:7/24/2014)... from Penn Medicine shows that incisionless transcatheter aortic ... stay by 30 percent and has no impact ... conventional transfemoral TAVR, which requires an incision in ... the current issue of Circulation: Cardiovascular Interventions ... aortic valve without a traditional open-heart surgical approach. ...
(Date:7/24/2014)... PROVIDENCE, R.I. Lynn E. Taylor, M.D., director ... states in the July, 2014 Rhode Island ... C" that eliminating hepatitis c virus infection (hep ... benefits, enhance capacity to address other health challenges, ... HCV in the United States, Taylor says, include ...
Breaking Medicine News(10 mins):Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4
... , FRIDAY, March 25 (HealthDay News) -- A small army ... of sick and dying animals from a rural North Carolina ... More than 400 animals -- 17 species in all, ... had been living in squalor with a middle-aged couple claiming ...
... FRIDAY, March 25 (HealthDay News) -- People looking for a ... joints sometimes turn to biking. Rather than a 30-minute jog ... hours on the bike, with little or no joint strain. ... physical activity raise a new problem: How to keep the ...
... Aurora, Colo. (March 24, 2011)A research team at the University ... be used to diagnose colon cancer earlier. It is possible ... the cancer. Colon cancer is the third most common cancer ... it, according to the American Cancer Society. This enzyme biomarker ...
... The US Food and Drug Administration announced today that ... the treatment of patients with metastatic melanoma. It is the ... with advanced melanoma. Ipilimumab uses a novel approach known ... attack cancer. The therapy, originally known as anti-CTLA-4, was developed ...
... Research Chair Peter Shizgal who investigates the roots ... recognized by his peers with the prestigious Prix Adrien ... Psychology and a member of the Centre for Studies ... qubcoise pour la recherche en psychologie (Quebec Society for ...
... , FRIDAY, March 25 (HealthDay News) -- A poor diet ... postmenopausal women, a new study has found. Researchers analyzed ... found that deficiencies in more than a single nutrient were ... Risk increased 44 percent with deficiencies in three nutrients. ...
Cached Medicine News:Health News:Animal 'Hoarding' Often Tied to Mental Illness 2Health News:Animal 'Hoarding' Often Tied to Mental Illness 3Health News:Animal 'Hoarding' Often Tied to Mental Illness 4Health News:Cyclists Urged to Prep Their Bodies for the Long Haul 2Health News:Cyclists Urged to Prep Their Bodies for the Long Haul 3Health News:University of Colorado team identifies new colon cancer marker 2Health News:Novel immunotherapy drug receives FDA approval for the treatment of metastatic melanoma 2Health News:Peter Shizgal distinguished by his peers 2Health News:Poor Eating Habits May Lead to Anemia in Older Women 2
(Date:7/24/2014)... -- Delivery of the Report will take 2-3 ... Photo - http://photos.prnewswire.com/prnh/20140723/129707 ... on Global and Chinese Hemodialysis Machine industry. The ... Machine including its classification, application and manufacturing technology. ... manufacturers of Hemodialysis Machine listing their product specification, ...
(Date:7/24/2014)... 24, 2014 Cancer patients in the west of ... cancer treatment closer to home when a new radiotherapy center ... Medical Systems (NYSE: VAR ) has been selected ... in June for four TrueBeam™ medical linear accelerators. ... and efficient radiotherapy and radiosurgery treatments, will replace older treatment ...
(Date:7/24/2014)... July 24, 2014  Blueprint Medicines (Blueprint), a leader ... cancer patients, today announced the appointment of Jeffrey ... joins Blueprint from Algeta ASA, where he served on ... the acquisition by Bayer. Mr. Albers succeeds Alexis ... Partner at Third Rock Ventures, who will remain an ...
Breaking Medicine Technology:Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer 2
... (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, ... at the Wedbush Life Sciences Conference in New York on ... Interested parties may access a live audio webcast of the ... www.BMRN.com .  A replay of the call will be ...
... Merck,s Schering-Plough unit current and former pharmaceutical representatives ... opinion issued by a Federal Court in Connecticut. ... The law firms of Joseph, Herzfeld, Hester ... represent the plaintiffs in a Nationwide Collective Law Suit. ...
Cached Medicine Technology:BioMarin to Present at the Wedbush Life Sciences Conference 2UPDATE: Total Victory for Schering-Plough (Now Merck) Pharmaceutical Reps in National Suit for Overtime Pay 2
... Hand Implant System utilizes the same proven ... replacements. The SR™ Hand Implant System ... prostheses including minimal bone resection, surface replacement ... surfaces, retention and/or repositioning of the ligamentous ...
... the NeuFlex™ MCP and/or PIP ... on numerous research studies of ... the MCP/PIP joint. This prosthesis ... the phalanx, by settling the ...
... Blackstone Anterior Cervical Plate System ... implantation. The innovative design of ... prevents screw back-out. The implant ... Simple, reliable instrumentationincluding innovations like ...
... closely match the natural anatomy of ... Titanium construction incorporates an 8-degree cranial ... design prevents screws from backing out. ... for X-ray control of the procedure. ...
Medicine Products: